MWA Asset Management’s Pfizer PFE Stock Holding History

MWA Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,665	Closed	-$309K	–	132
2024 Q3	$309K	Sell	10,665 -535	-5%	-$15.6K	0.21%	106
2024 Q2	$313K	Sell	11,200 -1,815	-14%	-$50K	0.22%	101
2024 Q1	$361K	Buy	13,015 +5,420	+71%	+$150K	0.26%	91
2023 Q4	$219K	Sell	7,595 -1,862	-20%	-$56.3K	0.18%	107
2023 Q3	$314K	Buy	+9,457	New	+$334K	0.3%	89

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MWA Asset Management's PFE Position: Q4 2024 in Review

MWA Asset Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 10,665 shares — an estimated $309K sold.

MWA Asset Management first reported a position in PFE in Q3 2023 and held it in 5 quarters. The position peaked at $361K in Q1 2024. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

MWA Asset Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
MWA Asset Management sold 10,665 Pfizer shares in Q4 2024, an estimated $309K.
MWA Asset Management first reported a position in Pfizer in Q3 2023 and held it in 5 quarters.
MWA Asset Management's Pfizer position peaked at $361K in Q1 2024.
2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on MWA Asset Management's 13F filing for Q4 2024, filed 28 Jan 2025.